These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported Terminated 2008-002662-56 Preoperative administration of controlled-release oxycodone vs morphine as transition oppioid for TIVA in pain control post VATS 2010-01-15 due-trials
Completed, but no date 2008-002697-35 A dose-finding study of Docetaxel, Oxaliplatin and Capecitabine (TEX) as First-Line Treatment in Patients with Advanced Gastric Cancer bad-data
Completed, but no date 2008-003925-17 Immunotherapy by autologous peripheral blood mononuclear cells and GM-CSF for hepatocellular carcinoma undergoing radiofrequency thermal ablation bad-data
Not reported Terminated 2008-004138-26 USE OF ABATACEPT IN ANCA-ASSOCIATED VASCULITIS 2008-10-08 due-trials
Not reported 2008-007287-42 Ivabradine in multislice CT: comparison with metoprolol in the reduction of motion artefacts and in the improvement of diagnostic care. 2010-09-30 due-trials
Completed, but no date Terminated 2008-007353-12 METHOTREXATE AS STEROID-SPARING AGENT IN IDIOPATHIC RETROPERITONEAL FIBROSIS: A MULTICENTRE RANDOMISED CONTROLLED TRIAL bad-data
Completed, but no date 2009-013004-31 Early combined prolonged release ropinirole and rasagiline therapy in newly diagnosed patients with Parkinsons disease. A prospective, randomized, parallel groups, long-term follow-up study includ... bad-data
Completed, but no date 2009-013198-16 Acute Myocardial Infarction and endothelial function. Assessment with a non invasive ultrasonographic computerized method during oral vitamin C supplementation. bad-data
Completed, but no date 2009-016686-28 Evaluation of [18F]Fluorocholine PET/CT imaging for staging and restaging of prostate cancer bad-data
Completed, but no date 2010-018853-36 Switching from beta blocker monotherapy to either ganfort � or cosopt �. A three months, single-blind , parallel group, randomized clinical trial in ocular hypertension/primary open angle glaucoma. bad-data
Completed, but no date Terminated 2010-020010-28 EVALUATION OF RESPIRATORY MUSCLES` FUNCTION IN PATIENTS AFFECTED BY ALS WITH HEAVY METAL POISONING bad-data
Not reported Terminated 2011-002719-27 GLUCOSE METABOLISM AND INFLAMMATORY PARAMETERS UNDER IGF-I TREATMENT IN CYSTIC FIBROSIS 2013-11-15 due-trials
Completed, but no date 2011-002911-27 Effect of boceprevir therapy on HCV-specific T cell responses: perspectives of immune monitoring and immune therapy bad-data
Ongoing 2011-006302-28 Dopamine modulation of oxytocin prosocial effects not-yet-due
Not reported Terminated 2012-004138-41 Anti-viral T cell responses in patients with chronic HCV infection treated with telaprevir: can therapy induce functional T cell reconstitution? 2015-09-15 due-trials
Not reported 2012-005399-32 Randomized, open label, two parallel arms, intervention trial comparing the effect of DPP-IV inhibitor Vildagliptin vs. Glibenclamide on circulating EPCs. 2016-06-10 due-trials
Completed, but no date 2014-000574-19 Experimental study for the evaluation of the effect of radioactive iodine therapy on free thyroxine circulating levels after oral administration of sodium levo-thyroxine in patients thyroidectomized ... bad-data
Completed, but no date Terminated 2014-001207-42 Multicenter randomized trial comparing erlotinib vs mono-chemotherapy in the third-line treatment of non-small cell lung cancer (NSCLC) patients with EGFR-mutated or unknown bad-data
Ongoing 2014-001303-52 Treatment of relapsed/refractory leukemia with intravenous administration of Dacarbazine not-yet-due
Ongoing 2014-003894-41 Effect of a Peg-interferon alfa 2A pulse on HBV-specific T cell responses in chronic hepatitis HBeAg negative patients under long-term nucleos(t)ide treatment not-yet-due
Completed, but no date Terminated 2014-004395-28 Phase II randomized study of maintenance regorafenib vs placebo in no progression patients after first-line platinum and fluoropyrimidines based chemotherapy in HER2 negative locally advanced/metastat... bad-data